MedTrace Logo

MIRs03: Paravertebral Block With Ropivacaine Before Breast Cancer Surgery

NCT02408393 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 380

Last updated 2019-07-10

No results posted yet for this study

Summary

Compare the effect of paravertebral block (PVB) with Ropivacaine or placebo on the incidence of chronic pain 3 months after breast cancer surgery.

Conditions

  • Malignant Neoplasm of Breast

Interventions

DRUG

Saline

DRUG

Ropivacaine

Sponsors & Collaborators

  • Institut Curie

    lead OTHER

Principal Investigators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-27
Primary Completion
2018-07-31
Completion
2019-03-09

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02408393 on ClinicalTrials.gov